17Interstrand crosslinks (ICLs) represent a highly toxic form of DNA damage that can block 18 essential biological processes including DNA replication and transcription. To combat their 19 deleterious effects all eukaryotes have developed cell cycle-dependent repair strategies that co-20 opt various factors from 'classical' DNA repair pathways to resolve such lesions. Here, we 21 report that Trypanosoma brucei, the causative agent of African trypanosomiasis, possesses 22 such systems that show some intriguing differences to those mechanisms expressed in other 23 organisms. Following the identification of trypanosomal homologues encoding for CSB, 24 EXO1, SNM1, MRE11, RAD51 and BRCA2, gene deletion coupled with phenotypic studies 25 demonstrated that all the above factors contribute to this pathogen's ICL REPAIRtoire with 26 their activities split across two epistatic groups. We show that one network, which encompasses 27 TbCSB, TbEXO1 and TbSNM1, may operate throughout the cell cycle to repair ICLs 28 encountered by transcriptional detection mechanisms while the other relies on homologous 29 recombination enzymes that together may resolve lesions responsible for the stalling of DNA 30 replication forks. By unravelling and comparing the T. brucei ICL REPAIRtoire to those 31 systems found in its host, targets amenable to inhibitor design may be identified and could be 32 used alongside trypanocidal ICL-inducing agents to exacerbate their effects. 33 34 Author summary 35 Parasites belonging to the Trypanosoma brucei complex cause a human and animal infections 36 collectively known as African trypanosomiasis. Drugs used against these diseases are 37 problematic as medical supervision is required for administration, they are costly, have limited 38 efficacy, may cause unwanted side effects while drug resistance is emerging. Against this 39 backdrop, there is a need for new therapies targeting these neglected tropical 40 diseases. Previous studies have shown compounds that induce DNA interstrand crosslinks 41 (ICLs) formation are effective trypanocidal agents with the most potent invariably functioning 42 as prodrugs. Despite the potential of ICL-inducing compounds to treat African trypanosomiasis 43 little is known about the ICL repair mechanisms expressed by trypanosomes. Using a 44 combination of gene deletion and epistatic analysis we report the first systematic dissection of 45 how ICL repair might operate in T. brucei, a diverged eukaryote. It sheds light on the 46 conservation and divergence of ICL repair in one of only a handful of protists that can be 47 studied genetically, and offers the promise of developing or exploiting ICL-causing agents as 48 3 new anti-parasite therapies. These findings emphasise the novelty and importance of 49 understanding ICL repair in T. brucei and, more widely, in non-model eukaryotes.50 51 52 Spread by the hematophagous feeding behaviour of tsetse flies, protozoan parasites 53 belonging to the Trypanosoma brucei species complex are responsible for a group of human 54 and anim...